Codexis, Inc. (CDXS)
Nasdaq · Industrial Organic Chemicals · Manufacturing · CIK 1200375 · fiscal year ends in Dec
Closing price $1.20 on 30 Oct 2026; 52-week range $0.98 to $2.85.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $77.7M
- Revenue growth
- 35.9%
- Net income, last twelve months
- -$30.7M
- Earnings per share
- -$0.34
- Gross margin
- 87.0%
- Operating margin
- -35.6%
- Net margin
- -39.6%
- Free cash flow
- -$12.2M
- Return on equity
- -93.2%
- Market value
- $109.7M
- Cash
- $27.2M
- Debt
- $40.9M
- Debt to equity
- 1.24
- Shares outstanding
- 91.4M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $70.4M | -$41.7M | -$44.0M | -$0.50 | -$23.8M | 10-K filed 11 Mar 2026 |
| FY2024 | 31 Dec 2024 | $59.3M | -$58.5M | -$65.3M | -$0.89 | -$53.7M | 10-K filed 27 Feb 2025 |
| FY2023 | 31 Dec 2023 | $70.1M | -$68.1M | -$76.2M | -$1.12 | -$57.1M | 10-K filed 28 Feb 2024 |
| FY2022 | 31 Dec 2022 | $138.6M | -$34.9M | -$33.6M | -$0.51 | $3.0M | 10-K filed 27 Feb 2023 |
| FY2021 | 31 Dec 2021 | $104.8M | -$22.7M | -$21.3M | -$0.33 | -$28.1M | 10-K filed 28 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $14.9M | -$12.0M | -$0.13 |
| Q1 FY2026 | 31 Mar 2026 | $15.2M | -$8.7M | -$0.10 |
| Q4 FY2025 | 31 Dec 2025 | $38.9M | $9.6M | $0.11 |
| Q3 FY2025 | 30 Sep 2025 | $8.6M | -$19.6M | -$0.22 |
| Q2 FY2025 | 30 Jun 2025 | $15.3M | -$13.3M | -$0.16 |
| Q1 FY2025 | 31 Mar 2025 | $7.5M | -$20.7M | -$0.25 |
| Q4 FY2024 | 31 Dec 2024 | $21.5M | -$10.4M | -$0.13 |
| Q3 FY2024 | 30 Sep 2024 | $12.8M | -$20.6M | -$0.29 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Research and development revenue | $44.4M | 63.0% |
| Product revenue | $26.0M | 37.0% |
By region, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Americas | $43.5M | 61.9% |
| APAC | $17.6M | 24.9% |
| EMEA | $9.3M | 13.2% |
Company events
The newest 8-K filings of 189 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 11 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 27 Jul 2026 | 8-K | Other events | 8.01, 9.01 |
| 23 Jul 2026 | 8-K | Results, Other events | 2.02, 8.01 |
| 22 Jun 2026 | 8-K | Shareholder vote | 5.07 |
| 7 May 2026 | 8-K | Results | 2.02, 9.01 |
| 14 Apr 2026 | 8-K | Leadership change | 5.02 |
| 11 Mar 2026 | 8-K | Results | 2.02, 9.01 |
| 6 Nov 2025 | 8-K | Results, Leadership change, Restructuring | 2.02, 2.05, 5.02, 9.01 |
| 13 Aug 2025 | 8-K | Results | 2.02, 9.01 |
| 11 Jun 2025 | 8-K | Leadership change, Shareholder vote | 5.02, 5.07 |
| 14 May 2025 | 8-K | Results | 2.02, 9.01 |
| 9 Apr 2025 | 8-K | Leadership change, Investor update | 5.02, 7.01, 9.01 |
Every filing
The newest filings with the SEC of 391 held.
| Filed | Form | Period |
|---|---|---|
| 11 Aug 2026 | 10-Q | 30 Jun 2026 |
| 11 Aug 2026 | 8-K | 11 Aug 2026 |
| 27 Jul 2026 | 8-K | 23 Jul 2026 |
| 23 Jul 2026 | 8-K | 23 Jul 2026 |
| 22 Jun 2026 | 8-K | 17 Jun 2026 |
| 7 May 2026 | 10-Q | 31 Mar 2026 |
| 7 May 2026 | 8-K | 7 May 2026 |
| 28 Apr 2026 | ARS | 31 Dec 2025 |
| 28 Apr 2026 | DEFA14A | – |
| 28 Apr 2026 | DEF 14A | 17 Jun 2026 |
| 14 Apr 2026 | 8-K | 8 Apr 2026 |
| 11 Mar 2026 | 10-K | 31 Dec 2025 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 12 Oct 2026 | Erbez Georgia, See Remarks | Sale outside a trading plan | 6,335 | $1.36 | $8.6K | 60,475 | 14 Oct 2026 |
| 12 Oct 2026 | Moore Alison, President and CEO | Sale outside a trading plan | 6,335 | $1.36 | $8.6K | 244,171 | 14 Oct 2026 |
| 11 Jun 2026 | De Vre Raymond, Director | Sale outside a trading plan | 2,605 | $2.37 | $6.2K | 84,811 | 11 Jun 2026 |
| 24 Feb 2026 | Lutz Stefan, Chief Scientific Officer | Sale outside a trading plan | 5,862 | $1.13 | $6.6K | 130,421 | 25 Feb 2026 |
| 6 Feb 2026 | Lutz Stefan, Chief Scientific Officer | Sale outside a trading plan | 2,492 | $1.31 | $3.3K | 136,283 | 9 Feb 2026 |
| 6 Feb 2026 | Erbez Georgia, See Remarks | Sale outside a trading plan | 3,826 | $1.31 | $5.0K | 66,810 | 9 Feb 2026 |
| 6 Feb 2026 | Moore Alison, President and CEO | Sale outside a trading plan | 3,826 | $1.31 | $5.0K | 250,506 | 9 Feb 2026 |
| 7 Jan 2026 | Lutz Stefan, CSO | Sale outside a trading plan | 4,685 | $1.70 | $8.0K | 138,775 | 8 Jan 2026 |
| 1 Dec 2025 | Opaleye Management Inc., 10% owner | Sale outside a trading plan | 245,000 | $1.67 | $408.5K | 9,955,000 | 1 Dec 2025 |
| 1 Dec 2025 | Opaleye Management Inc., 10% owner | Sale outside a trading plan | 8,533 | $1.67 | $14.2K | 179,989 | 1 Dec 2025 |
| 28 Nov 2025 | Opaleye Management Inc., 10% owner | Sale outside a trading plan | 105,000 | $1.75 | $183.8K | 10,200,000 | 1 Dec 2025 |
| 28 Nov 2025 | Opaleye Management Inc., 10% owner | Sale outside a trading plan | 2,490 | $1.75 | $4.4K | 188,522 | 1 Dec 2025 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 13 Oct 2026 | Erbez Georgia, Officer | 6,335 | $8.6K | 12 Oct 2026 |
| 13 Oct 2026 | MOORE ALISON, Officer | 6,335 | $8.6K | 12 Oct 2026 |
| 23 Feb 2026 | Lutz Stefan, Officer | 5,280 | $6.2K | 24 Feb 2026 |
| 6 Feb 2026 | Lutz Stefan, Officer | 2,460 | $3.1K | 6 Feb 2026 |
| 6 Feb 2026 | Norrett Kevin, Officer, Former Chief Operating Officer | 3,291 | $4.2K | 6 Feb 2026 |
| 16 Jan 2026 | KEVIN NORRETT, Officer | 1,745 | $2.9K | 16 Jan 2026 |
| 7 Jan 2026 | Norrett Kevin, Officer | 6,123 | $10.4K | 7 Jan 2026 |
| 21 Nov 2025 | DENNIS P WOLF, Officer | 8,952 | $14.0K | 21 Nov 2025 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 30 Oct 2026 | Aberdeen Group plc | 13G amended | 9.86% | 10.8M |
| 13 Aug 2026 | LYTTON LAURENCE W | 13G amended | 5.2% | 5.6M |
| 29 Jul 2026 | Telemark Asset Management, LLC | 13G | 7.3% | 7.8M |
| 20 Jul 2026 | Aberdeen Group plc | 13G amended | 7.45% | 6.8M |
| 5 May 2026 | Opaleye Management Inc. | 13G amended | 7.47% | 6.8M |
| 14 Apr 2026 | Integrated Core Strategies (US) LLC | 13G | 5.2% | 4.7M |
| 26 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 11 Mar 2026 | LYTTON LAURENCE W | 13G | 5% | 4.5M |
| 23 Jan 2026 | Opaleye Management Inc. | 13G amended | 7.52% | 6.8M |
| 15 Jan 2026 | Aberdeen Group plc | 13G amended | 8.82% | 8.0M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 5.0M | +2.37% | 6.31 |
| 30 Sep 2026 | 4.8M | +20.23% | 5 |
| 15 Sep 2026 | 4.0M | +4.59% | 5.74 |
| 31 Aug 2026 | 3.8M | +3.32% | 3.56 |
| 14 Aug 2026 | 3.7M | -5.12% | 3.33 |
| 31 Jul 2026 | 3.9M | +4.72% | 2.06 |
| 15 Jul 2026 | 3.7M | +16.05% | 5.01 |
| 30 Jun 2026 | 3.2M | -0.79% | 3.04 |
Funds that hold it
From each fund's latest Form 13F.
160 funds held it at 30 Jun 2026: 87 added and 35 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 7,284,352 | $16.5M | +255,579 |
| Nantahala Capital Management, LLC | 7,247,226 | $16.4M | – |
| Opaleye Management Inc. | 6,785,000 | $15.3M | 0 |
| Aberdeen Group plc | 6,769,954 | $15.3M | -1,910,414 |
| Millennium Management LLC | 5,549,139 | $12.5M | +1,551,009 |
| Telemark Asset Management, LLC | 3,846,411 | $8.7M | 0 |
| Ameriprise Financial Inc. | 3,809,440 | $8.6M | +408,944 |
| Vanguard Capital Management LLC | 3,617,109 | $8.2M | -51,398 |
| Assenagon Asset Management S.A. | 2,556,412 | $5.8M | – |
| Geode Capital Management, LLC | 2,162,393 | $4.9M | +277,040 |
Peers
Companies in the same industry.
- International Flavors & Fragrances Inc. (IFF): revenue $10.0B, market value $23.7B
- LyondellBasell Industries N.V. (LYB): revenue –, market value $22.2B
- Westlake Corp. (WLK): revenue $11.3B, market value $8.7B
- Newmarket Corp. (NEU): revenue $2.8B, market value $7.2B
- Sensient Technologies Corp. (SXT): revenue $1.7B, market value $5.0B
- REX American Resources Corp. (REX): revenue $658.6M, market value $1.3B
- Green Plains Inc. (GPRE): revenue $1.8B, market value $989.8M
- Westlake Chemical Partners LP (WLKP): revenue $1.2B, market value $756.9M
- Gevo, Inc. (GEVO): revenue $177.5M, market value $311.5M
- Alto Ingredients, Inc. (ALTO): revenue $943.3M, market value $283.2M